Company

Pearl Therapeutics, Inc.

Pearl Therapeutics develops inhaled medicines for respiratory diseases.

About

Pearl Therapeutics focuses on inhalation products and drug delivery technologies for respiratory conditions. The company was founded in 2006 and is based in Redwood City, US. AstraZeneca acquired it in June 2013 for an initial USD 560 mn, with potential additional milestone payments.

6Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in